FFCP PHASE1:Mm9::chr5:38893346..38893365,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=117591|HGNC=|MCL_coexpression_id=37|UniProt=Q99JJ2|association_with_transcript=25bp_to_ENSMUST00000005238,NM_145559,uc008xgr.1,uc012dvp.1_5end|description=CAGE_peak_5_at_Slc2a9_5end|id=chr5:38893346..38893365,-|ontology_enrichment_celltype=CL:0000710!2.90e-11!1;CL:0002077!2.90e-11!1;CL:0005014!2.90e-11!1;CL:0002315!2.90e-11!1;CL:0002490!2.90e-11!1|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0001911!4.07e-21!2;UBERON:0000076!4.07e-21!2;UBERON:0005333!4.07e-21!2;UBERON:0008425!4.07e-21!2;UBERON:0005311!4.07e-21!2;UBERON:0005153!1.12e-09!17;UBERON:0005085!1.37e-07!13|ontology_enrichment_uberon_v019_2=UBERON:0001911,1.87e-86,2;UBERON:0000076,1.87e-86,2;UBERON:0005333,1.87e-86,2;UBERON:0008425,1.87e-86,2;UBERON:0005311,1.87e-86,2;UBERON:0003100,5.67e-17,11;UBERON:0005085,1.42e-14,13;UBERON:0005153,1.86e-11,17;UBERON:0005157,6.23e-10,20;UBERON:0002365,3.41e-08,25;UBERON:0002330,3.41e-08,25|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.422530259330042,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.278047249225598,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0701358198903186,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.195133647857799,0,0,0,0,0.172684981865896,0,0,0,49.6681915749227,45.5295631402809,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.100966449948148,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.192906610981141,0,0,0,0,0,0|short_description=p5@Slc2a9}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=117591 | |||
|HGNC= | |||
|MCL_coexpression_id=37 | |||
|TSSclassifier=NA | |||
|UniProt=Q99JJ2 | |||
|association_with_transcript=25bp_to_ENSMUST00000005238,NM_145559,uc008xgr.1,uc012dvp.1_5end | |||
|cluster_id=chr5:38893346..38893365,- | |||
|description=CAGE_peak_5_at_Slc2a9_5end | |||
|id=chr5:38893346..38893365,- | |||
|ontology_enrichment_celltype=CL:0000710!2.90e-11!1;CL:0002077!2.90e-11!1;CL:0005014!2.90e-11!1;CL:0002315!2.90e-11!1;CL:0002490!2.90e-11!1 | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0001911!4.07e-21!2;UBERON:0000076!4.07e-21!2;UBERON:0005333!4.07e-21!2;UBERON:0008425!4.07e-21!2;UBERON:0005311!4.07e-21!2;UBERON:0005153!1.12e-09!17;UBERON:0005085!1.37e-07!13 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001911,1.87e-86,2;UBERON:0000076,1.87e-86,2;UBERON:0005333,1.87e-86,2;UBERON:0008425,1.87e-86,2;UBERON:0005311,1.87e-86,2;UBERON:0003100,5.67e-17,11;UBERON:0005085,1.42e-14,13;UBERON:0005153,1.86e-11,17;UBERON:0005157,6.23e-10,20;UBERON:0002365,3.41e-08,25;UBERON:0002330,3.41e-08,25 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.422530259330042,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.278047249225598,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0701358198903186,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.195133647857799,0,0,0,0,0.172684981865896,0,0,0,49.6681915749227,45.5295631402809,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.100966449948148,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.192906610981141,0,0,0,0,0,0 | |||
|short_description=p5@Slc2a9 | |||
}} |
Latest revision as of 00:43, 26 September 2015
Short description: | p5@Slc2a9 |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_5_at_Slc2a9_5end |
Coexpression cluster: | MCL_coexpression_mm9:37 |
Association with transcript: | 25bp_to_ENSMUST00000005238, NM_145559, uc008xgr.1, uc012dvp.1_5end |
EntrezGene: | Slc2a9 |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
mammary gland | 1.87e-86 | 2 |
external ectoderm | 1.87e-86 | 2 |
mammary bud | 1.87e-86 | 2 |
mammary ridge | 1.87e-86 | 2 |
mammary placode | 1.87e-86 | 2 |
female organism | 5.67e-17 | 11 |
ectodermal placode | 1.42e-14 | 13 |
epithelial bud | 1.86e-11 | 17 |
epithelial fold | 6.23e-10 | 20 |
exocrine gland | 3.41e-08 | 25 |
exocrine system | 3.41e-08 | 25 |